1. Home
  2. TOVX
  3. TOVX News

Latest Theriva Biologics Inc. (TOVX) News on June 8, 2025

Theriva™ Biologics Announces Presentation of Data from VCN-01 Retinoblastoma Phase 1 Clinical Trial at ASCO 2025 and Investigator Meeting to Review Topline Data from the VIRAGE Phase 2b Trial of VCN-01 in Metastatic Pancreatic Cancer
TOVX

GlobeNewswire

12 days ago

Theriva™ Biologics Announces Presentation of Data from VCN-01 Retinoblastoma Phase 1 Clinical Trial at ASCO 2025 and Investigator Meeting to Review Topline Data from the VIRAGE Phase 2b Trial of VCN-01 in Metastatic Pancreatic Cancer

Theriva™ Biologics Reports First Quarter 2025 Operational Highlights and Financial Results
TOVX

GlobeNewswire

25 days ago

Theriva™ Biologics Reports First Quarter 2025 Operational Highlights and Financial Results

TOVX

Associated Press Finance

25 days ago

Theriva Biologics: Q1 Earnings Snapshot

Theriva Biologics Announces Closing of $7.5 Million Public Offering
TOVX

GlobeNewswire

a month ago

Theriva Biologics Announces Closing of $7.5 Million Public Offering

Theriva Biologics Announces Pricing of $7.5 Million Public Offering
TOVX

GlobeNewswire

a month ago

Theriva Biologics Announces Pricing of $7.5 Million Public Offering

Theriva™ Biologics Announces Primary Endpoints for Efficacy and Safety Achieved in VIRAGE Phase 2b Clinical Trial of VCN-01 with Gemcitabine/nab-Paclitaxel in Newly-Diagnosed Metastatic Pancreatic Cancer Patients
TOVX

GlobeNewswire

a month ago

Theriva™ Biologics Announces Primary Endpoints for Efficacy and Safety Achieved in VIRAGE Phase 2b Clinical Trial of VCN-01 with Gemcitabine/nab-Paclitaxel in Newly-Diagnosed Metastatic Pancreatic Cancer Patients

Theriva Biologics Announces Presentation of Data from the Phase 1b/2a Clinical Trial of SYN-004 (ribaxamase) in Allogeneic Hematopoietic Cell Transplant Recipients
TOVX

GlobeNewswire

2 months ago

Theriva Biologics Announces Presentation of Data from the Phase 1b/2a Clinical Trial of SYN-004 (ribaxamase) in Allogeneic Hematopoietic Cell Transplant Recipients

Theriva™ Biologics Announces Positive Outcomes from the Second Meeting of the Independent Data Monitoring Committee for VIRAGE, the Company’s Phase 2b Clinical Trial of VCN-01 in Combination with Chemotherapy for Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
TOVX

GlobeNewswire

2 months ago

Theriva™ Biologics Announces Positive Outcomes from the Second Meeting of the Independent Data Monitoring Committee for VIRAGE, the Company’s Phase 2b Clinical Trial of VCN-01 in Combination with Chemotherapy for Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)

Theriva™ Biologics to Present at the 2025 NeauxCancer Conference
TOVX

GlobeNewswire

3 months ago

Theriva™ Biologics to Present at the 2025 NeauxCancer Conference

Q1 Virtual Investor Summit: On-Demand Presentations Now Live
TOVX

ACCESS Newswire

3 months ago

Q1 Virtual Investor Summit: On-Demand Presentations Now Live

Theriva™ Biologics Reports Full-Year 2024 Operational Highlights and Financial Results
TOVX

GlobeNewswire

3 months ago

Theriva™ Biologics Reports Full-Year 2024 Operational Highlights and Financial Results

Theriva™ Biologics to Participate in the Q1 Investor Summit Virtual
TOVX

GlobeNewswire

3 months ago

Theriva™ Biologics to Participate in the Q1 Investor Summit Virtual

Theriva™ Biologics Announces U.S. FDA Guidance on Design of Phase 3 Study of VCN-01 for the Treatment of Metastatic Pancreatic Cancer
TOVX

GlobeNewswire

6 months ago

Theriva™ Biologics Announces U.S. FDA Guidance on Design of Phase 3 Study of VCN-01 for the Treatment of Metastatic Pancreatic Cancer

TOVX

Associated Press Finance

7 months ago

Theriva Biologics: Q3 Earnings Snapshot

Theriva Biologics Selected as Finalist in International Competition for Merck KGaA's EMEA Advance Biotech Grant
TOVX

GlobeNewswire

7 months ago

Theriva Biologics Selected as Finalist in International Competition for Merck KGaA's EMEA Advance Biotech Grant

TOVX

MT Newswires

8 months ago

Theriva Biologics Gets EU Orphan Drug Designation for Eye Cancer Treatment Candidate; Shares Rise

Theriva Biologics Announces Orphan Medicinal Product Designation Granted by the European Commission to VCN-01 for the Treatment of Retinoblastoma
TOVX

GlobeNewswire

8 months ago

Theriva Biologics Announces Orphan Medicinal Product Designation Granted by the European Commission to VCN-01 for the Treatment of Retinoblastoma

TOVX

MT Newswires

8 months ago

Theriva Shares Jump After Company Gets Recommendation to Continue SYN-004 Trial

Nano-Cap Theriva Biologics' Investigational Drug For Transplant-Related Complication Shows Safety In Bone Marrow Transplant Patients
TOVX

Benzinga

8 months ago

Nano-Cap Theriva Biologics' Investigational Drug For Transplant-Related Complication Shows Safety In Bone Marrow Transplant Patients

Theriva™ Biologics Announces Positive Outcome of Data and Safety Monitoring Committee (DSMC) Review in Phase 1b/2a Clinical Trial of SYN-004 (ribaxamase) in Allogeneic Hematopoietic Cell Transplant Recipients
TOVX

GlobeNewswire

8 months ago

Theriva™ Biologics Announces Positive Outcome of Data and Safety Monitoring Committee (DSMC) Review in Phase 1b/2a Clinical Trial of SYN-004 (ribaxamase) in Allogeneic Hematopoietic Cell Transplant Recipients

TOVX

MT Newswires

8 months ago

Theriva Biologics Shares Tumble After Pricing $2.5 Million Stock Offering

Theriva Biologics Announces Pricing of $2.5 Million Public Offering
TOVX

GlobeNewswire

8 months ago

Theriva Biologics Announces Pricing of $2.5 Million Public Offering

Theriva™ Biologics Achieves Target Patient Enrollment in the VIRAGE Phase 2b Trial of VCN-01 with Gemcitabine/nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer
TOVX

GlobeNewswire

9 months ago

Theriva™ Biologics Achieves Target Patient Enrollment in the VIRAGE Phase 2b Trial of VCN-01 with Gemcitabine/nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer

Theriva™ Biologics Awarded Manufacturing Funding from the Spanish Government’s National Knowledge Transfer Program
TOVX

GlobeNewswire

9 months ago

Theriva™ Biologics Awarded Manufacturing Funding from the Spanish Government’s National Knowledge Transfer Program

Upcoming Stock Splits This Week (August 26 to August 30) – Stay Invested
TOVX

TipRanks

9 months ago

Upcoming Stock Splits This Week (August 26 to August 30) – Stay Invested

Theriva Biologics Announces Reverse Stock Split
TOVX

GlobeNewswire

10 months ago

Theriva Biologics Announces Reverse Stock Split

TOVX

Associated Press Finance

10 months ago

Theriva Biologics: Q2 Earnings Snapshot

Theriva™ Biologics Reports Second Quarter 2024 Operational Highlights and Financial Results
TOVX

GlobeNewswire

10 months ago

Theriva™ Biologics Reports Second Quarter 2024 Operational Highlights and Financial Results

Theriva™ Biologics Receives Rare Pediatric Drug Designation by the U.S. FDA for VCN-01 for the Treatment of Retinoblastoma
TOVX

GlobeNewswire

10 months ago

Theriva™ Biologics Receives Rare Pediatric Drug Designation by the U.S. FDA for VCN-01 for the Treatment of Retinoblastoma

Catherine Wood's Strategic Acquisition of PagerDuty Inc Shares
TOVX

GuruFocus.com

a year ago

Catherine Wood's Strategic Acquisition of PagerDuty Inc Shares

ADM Animal Nutrition Expands Recall to Include Additional Lots of Various Feed Products
TOVX

Business Wire

a year ago

ADM Animal Nutrition Expands Recall to Include Additional Lots of Various Feed Products

Insider Sale at Cogent Communications Holdings Inc (CCOI): CFO Thaddeus Weed Sells 2,400 Shares
TOVX

GuruFocus.com

a year ago

Insider Sale at Cogent Communications Holdings Inc (CCOI): CFO Thaddeus Weed Sells 2,400 Shares

Factbox-Here's everything Apple announced at WWDC
TOVX

Reuters

a year ago

Factbox-Here's everything Apple announced at WWDC

Elon Musk's Tesla pay package: More shareholders speak out
TOVX

Yahoo Finance Video

a year ago

Elon Musk's Tesla pay package: More shareholders speak out

Cargojet enters charter deal for Chinese e-commerce
TOVX

FreightWaves

a year ago

Cargojet enters charter deal for Chinese e-commerce

Enghouse Releases Second Quarter Results
TOVX

CNW Group

a year ago

Enghouse Releases Second Quarter Results

AVENUE 8 DOUBLES DOWN ON GENERATIVE AI, SHIFTS FOCUS TO SIDEKICK PLATFORM FOR REAL ESTATE AGENTS
TOVX

PR Newswire

a year ago

AVENUE 8 DOUBLES DOWN ON GENERATIVE AI, SHIFTS FOCUS TO SIDEKICK PLATFORM FOR REAL ESTATE AGENTS

TOVX

MT Newswires

a year ago

Theriva Biologics Gets Fast Track Designation for Pancreatic Cancer Treatment

Theriva™ Biologics Announces Fast Track Designation Granted by the U.S. FDA for VCN-01 for the Treatment of Metastatic Pancreatic Cancer
TOVX

GlobeNewswire

a year ago

Theriva™ Biologics Announces Fast Track Designation Granted by the U.S. FDA for VCN-01 for the Treatment of Metastatic Pancreatic Cancer

Theriva™ Biologics to Participate in the A.G.P. Virtual Healthcare Conference
TOVX

GlobeNewswire

a year ago

Theriva™ Biologics to Participate in the A.G.P. Virtual Healthcare Conference

TOVX

Associated Press Finance

a year ago

Theriva Biologics: Q1 Earnings Snapshot

Theriva™ Biologics Reports First Quarter 2024 Operational Highlights and Financial Results
TOVX

GlobeNewswire

a year ago

Theriva™ Biologics Reports First Quarter 2024 Operational Highlights and Financial Results

Theriva™ Biologics to Discuss the Trial Design for VIRAGE - a Phase 2b Clinical Study of Systemically Administered VCN-01 in Combination with Chemotherapy in Pancreatic Ductal Adenocarcinoma - at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
TOVX

GlobeNewswire

a year ago

Theriva™ Biologics to Discuss the Trial Design for VIRAGE - a Phase 2b Clinical Study of Systemically Administered VCN-01 in Combination with Chemotherapy in Pancreatic Ductal Adenocarcinoma - at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Theriva™ Biologics Announces Positive Topline Data from Investigator Sponsored Phase 1 Trial of Intravitreal VCN-01 in Pediatric Patients with Refractory Retinoblastoma
TOVX

GlobeNewswire

a year ago

Theriva™ Biologics Announces Positive Topline Data from Investigator Sponsored Phase 1 Trial of Intravitreal VCN-01 in Pediatric Patients with Refractory Retinoblastoma

Theriva™ Biologics to Present Preclinical Data Supporting the Potential Synergy of VCN-01 and First-Line Pancreatic Cancer Chemotherapy Regimens at the American Society for Cell and Gene Therapy 27th Annual Meeting
TOVX

GlobeNewswire

a year ago

Theriva™ Biologics to Present Preclinical Data Supporting the Potential Synergy of VCN-01 and First-Line Pancreatic Cancer Chemotherapy Regimens at the American Society for Cell and Gene Therapy 27th Annual Meeting

Theriva™ Biologics Announces Presentation at the American Society for Cell and Gene Therapy 27th Annual Meeting
TOVX

GlobeNewswire

a year ago

Theriva™ Biologics Announces Presentation at the American Society for Cell and Gene Therapy 27th Annual Meeting

Theriva Biologics, Inc. (NYSE:TOVX) Q4 2023 Earnings Call Transcript
TOVX

Insider Monkey

a year ago

Theriva Biologics, Inc. (NYSE:TOVX) Q4 2023 Earnings Call Transcript

TOVX

Thomson Reuters StreetEvents

a year ago

Q4 2023 Theriva Biologics Inc Earnings Call

Theriva™ Biologics Reports Full-Year 2023 Operational Highlights and Financial Results
TOVX

GlobeNewswire

a year ago

Theriva™ Biologics Reports Full-Year 2023 Operational Highlights and Financial Results

Theriva™ Biologics to Host Conference Call and Webcast to Discuss Full Year 2023 Operational Highlights and Financial Results
TOVX

GlobeNewswire

a year ago

Theriva™ Biologics to Host Conference Call and Webcast to Discuss Full Year 2023 Operational Highlights and Financial Results

Theriva™ Biologics to Participate in the BIO-Europe Spring Conference
TOVX

GlobeNewswire

a year ago

Theriva™ Biologics to Participate in the BIO-Europe Spring Conference

Theriva Biologics Announces Positive Recommendation from the Independent Data Monitoring Committee of VIRAGE, the Phase 2b Clinical Trial of VCN-01 in Combination with Chemotherapy for Metastatic Pancreatic Ductal Adenocarcinoma
TOVX

GlobeNewswire

a year ago

Theriva Biologics Announces Positive Recommendation from the Independent Data Monitoring Committee of VIRAGE, the Phase 2b Clinical Trial of VCN-01 in Combination with Chemotherapy for Metastatic Pancreatic Ductal Adenocarcinoma

Citizens Community Bancorp, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
TOVX

Simply Wall St.

a year ago

Citizens Community Bancorp, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Home Federal Bancorp Inc of louisiana's Dividend Analysis
TOVX

GuruFocus.com

a year ago

Home Federal Bancorp Inc of louisiana's Dividend Analysis

TOVX

Argus Research

a year ago

Daily – Vickers Top Insider Picks for 01/25/2024

TOVX

Argus Research

a year ago

Daily – Vickers Top Insider Picks for 01/24/2024

Air T, Inc. Announces Dividend Dates for Air T Funding Alpha Income Preferred Securities (AIRTP)
TOVX

ACCESSWIRE

a year ago

Air T, Inc. Announces Dividend Dates for Air T Funding Alpha Income Preferred Securities (AIRTP)

Greenwave Technology Solutions Generates More than $9 Million Revenue in Q4 2023
TOVX

PR Newswire

a year ago

Greenwave Technology Solutions Generates More than $9 Million Revenue in Q4 2023

NETSOL Technologies appoints Jason Hurwitz as Sales Director of Europe
TOVX

GlobeNewswire

a year ago

NETSOL Technologies appoints Jason Hurwitz as Sales Director of Europe

Oncocyte to Present at the Sequire Investor Summit in Puerto Rico
TOVX

GlobeNewswire

a year ago

Oncocyte to Present at the Sequire Investor Summit in Puerto Rico

Theriva Biologics to Participate in the B. Riley Securities Annual Oncology Conference
TOVX

GlobeNewswire

a year ago

Theriva Biologics to Participate in the B. Riley Securities Annual Oncology Conference

Majority of Individuals with Atopic Dermatitis Improved with Arcutis’ Roflumilast Cream 0.15% According to New Data from Phase 3 Program
TOVX

GlobeNewswire

a year ago

Majority of Individuals with Atopic Dermatitis Improved with Arcutis’ Roflumilast Cream 0.15% According to New Data from Phase 3 Program

ZORYVE® (Roflumilast) Topical Foam, 0.3% Clears Seborrheic Dermatitis in Individuals Who Previously Reported an Inadequate Response to Topical Steroids
TOVX

GlobeNewswire

a year ago

ZORYVE® (Roflumilast) Topical Foam, 0.3% Clears Seborrheic Dermatitis in Individuals Who Previously Reported an Inadequate Response to Topical Steroids

VerifyMe to Host Investor Day on February 6, 2024
TOVX

PR Newswire

a year ago

VerifyMe to Host Investor Day on February 6, 2024

Mondee to Participate in 26th Annual Needham Growth Conference
TOVX

GlobeNewswire

a year ago

Mondee to Participate in 26th Annual Needham Growth Conference

The Container Store Group, Inc. Provides Business Update Ahead of 2024 ICR Conference Presentation
TOVX

Business Wire

a year ago

The Container Store Group, Inc. Provides Business Update Ahead of 2024 ICR Conference Presentation

Morgan Stanley Initiates Research Coverage on Mondee
TOVX

GlobeNewswire

a year ago

Morgan Stanley Initiates Research Coverage on Mondee

Zacks Industry Outlook Highlights Dorian LPG, EuroDry and Kirby
TOVX

Zacks

a year ago

Zacks Industry Outlook Highlights Dorian LPG, EuroDry and Kirby

Genprex Provides Business Update and Outlook for 2024
TOVX

PR Newswire

a year ago

Genprex Provides Business Update and Outlook for 2024

Red Robin (RRGB) Sees a More Significant Dip Than Broader Market: Some Facts to Know
TOVX

Zacks

a year ago

Red Robin (RRGB) Sees a More Significant Dip Than Broader Market: Some Facts to Know

Vintage Wine Estates Names Ryan Watson as Chief Marketing Officer
TOVX

Business Wire

a year ago

Vintage Wine Estates Names Ryan Watson as Chief Marketing Officer

Pixelworks to Present at Upcoming Investor Conferences
TOVX

PR Newswire

a year ago

Pixelworks to Present at Upcoming Investor Conferences

TOVX

ACCESSWIRE

a year ago

iAccess Alpha Tax Loss Recovery Summit 2024 - Buyside Best Ideas January 9th-10th 2024

ADC Therapeutics Regains Compliance with NYSE Continued Listing Standards
TOVX

GlobeNewswire

a year ago

ADC Therapeutics Regains Compliance with NYSE Continued Listing Standards

Pixelworks X7 Gen 2 Visual Processor Makes Debut in OnePlus Ace 3 Smartphone
TOVX

PR Newswire

a year ago

Pixelworks X7 Gen 2 Visual Processor Makes Debut in OnePlus Ace 3 Smartphone

Tortoise Provides Unaudited Balance Sheet Information and Asset Coverage Ratio Updates as of December 29, 2023, for TYG, NTG, TTP, NDP and TPZ
TOVX

ACCESSWIRE

a year ago

Tortoise Provides Unaudited Balance Sheet Information and Asset Coverage Ratio Updates as of December 29, 2023, for TYG, NTG, TTP, NDP and TPZ

The Container Store Group, Inc. Announces Participation in the 2024 ICR Conference
TOVX

Business Wire

a year ago

The Container Store Group, Inc. Announces Participation in the 2024 ICR Conference

EDSA: Updated Phase 3 Protocol for EB05 Trial Approved by Canadian Regulators…
TOVX

Zacks Small Cap Research

a year ago

EDSA: Updated Phase 3 Protocol for EB05 Trial Approved by Canadian Regulators…

New to The Street Announces its Five Corporate Guest Appearances, Show Airs as Sponsored Programming on Bloomberg TV and the FOX Business Network; Broadcastings Begin on Saturday, December 23, 2023, at 6:30 PM ET
TOVX

GlobeNewswire

a year ago

New to The Street Announces its Five Corporate Guest Appearances, Show Airs as Sponsored Programming on Bloomberg TV and the FOX Business Network; Broadcastings Begin on Saturday, December 23, 2023, at 6:30 PM ET

Evaxion Biotech Announces Closing of Private Placement
TOVX

GlobeNewswire

a year ago

Evaxion Biotech Announces Closing of Private Placement

Equillium Announces Update on Multi-Cytokine Inhibitors EQ101 & EQ102 in Development for Alopecia Areata and Celiac Disease
TOVX

Business Wire

a year ago

Equillium Announces Update on Multi-Cytokine Inhibitors EQ101 & EQ102 in Development for Alopecia Areata and Celiac Disease

Annexon Announces Pricing of $125.0 Million Underwritten Public Offering of Common Stock
TOVX

GlobeNewswire

a year ago

Annexon Announces Pricing of $125.0 Million Underwritten Public Offering of Common Stock

Tonix Pharmaceuticals Announces Highly Statistically Significant and Clinically Meaningful Topline Results in Second Positive Phase 3 Clinical Trial of TNX-102 SL for the Management of Fibromyalgia
TOVX

GlobeNewswire

a year ago

Tonix Pharmaceuticals Announces Highly Statistically Significant and Clinically Meaningful Topline Results in Second Positive Phase 3 Clinical Trial of TNX-102 SL for the Management of Fibromyalgia

Ouster Achieves ISO 27001 InfoSec Certification
TOVX

Business Wire

a year ago

Ouster Achieves ISO 27001 InfoSec Certification

Greenland Technologies to Present at Water Tower Research Investor Conference
TOVX

PR Newswire

a year ago

Greenland Technologies to Present at Water Tower Research Investor Conference

TOVX

Business Wire

a year ago

The Beachbody Company, Inc. Announces $5,300,000 Registered Direct Offering

GlycoMimetics Announces Independent Presentations on Uproleselan at American Society of Hematology Annual Meeting including New Clinical Data in Treated Secondary Acute Myeloid Leukemia
TOVX

Business Wire

a year ago

GlycoMimetics Announces Independent Presentations on Uproleselan at American Society of Hematology Annual Meeting including New Clinical Data in Treated Secondary Acute Myeloid Leukemia

Altisource Asset Management Corporation Reports Key Ruling in Blackrock and PIMCO Litigation
TOVX

Business Wire

2 years ago

Altisource Asset Management Corporation Reports Key Ruling in Blackrock and PIMCO Litigation

Lavie Bio Announces a Distribution Agreement with WinField United Canada for its Bio-Inoculant Seed Treatment Yalos™
TOVX

PR Newswire

2 years ago

Lavie Bio Announces a Distribution Agreement with WinField United Canada for its Bio-Inoculant Seed Treatment Yalos™

Presenting on the Emerging Growth Conference 65 Day 1 on December 6th Register Now
TOVX

GlobeNewswire

2 years ago

Presenting on the Emerging Growth Conference 65 Day 1 on December 6th Register Now

Culp, Inc. (CULP) Reports Q2 Loss, Tops Revenue Estimates
TOVX

Zacks

2 years ago

Culp, Inc. (CULP) Reports Q2 Loss, Tops Revenue Estimates

Companies Like Intellicheck (NASDAQ:IDN) Can Afford To Invest In Growth
TOVX

Simply Wall St.

2 years ago

Companies Like Intellicheck (NASDAQ:IDN) Can Afford To Invest In Growth

TOVX

GlobeNewswire

2 years ago

BOS Reports Financial Results for the Third Quarter of the Year 2023

Turnstone Biologics to Participate in the Piper Sandler 35th Annual Healthcare Conference
TOVX

GlobeNewswire

2 years ago

Turnstone Biologics to Participate in the Piper Sandler 35th Annual Healthcare Conference

Great week for Intevac, Inc. (NASDAQ:IVAC) institutional investors after losing 31% over the previous year
TOVX

Simply Wall St.

2 years ago

Great week for Intevac, Inc. (NASDAQ:IVAC) institutional investors after losing 31% over the previous year

Nuvectis Pharma Insiders Added US$3.75m Of Stock To Their Holdings
TOVX

Simply Wall St.

2 years ago

Nuvectis Pharma Insiders Added US$3.75m Of Stock To Their Holdings

Thomas Vo Spends US$114k On Nutex Health Stock
TOVX

Simply Wall St.

2 years ago

Thomas Vo Spends US$114k On Nutex Health Stock

BODi Helps End After-Dinner Suffering This Thanksgiving
TOVX

Business Wire

2 years ago

BODi Helps End After-Dinner Suffering This Thanksgiving

Salt Life continues brick-and-mortar expansion with Virginia store opening next month
TOVX

Retail Dive

2 years ago

Salt Life continues brick-and-mortar expansion with Virginia store opening next month

Shareholders in Dyadic International (NASDAQ:DYAI) are in the red if they invested three years ago
TOVX

Simply Wall St.

2 years ago

Shareholders in Dyadic International (NASDAQ:DYAI) are in the red if they invested three years ago

Share on Social Networks: